Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision tag appears on the page: Revision: v3.5.4, indicating the page has been updated to the latest revision. The previous revision label (v3.5.3) is removed.
    Difference
    0.0%
    Check dated 2026-05-15T02:10:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, reflecting a minor metadata update to the page. This change does not modify study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:41.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:10:25.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the v3.4.3 entry has been removed.
    Difference
    0.0%
    Check dated 2026-03-25T20:35:20.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:21:20.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the page. The lapse-in-funding notice and the Revision: v3.4.1 entry have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:49:44.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.